{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-24-000985","form_type":"8-K","ticker":"AEMD","cik":"0000882291","company_name":"AETHLON MEDICAL INC","filed_at":"2024-02-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.126268+00:00","generated_at":"2026-06-06T02:54:00.310146+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Aethlon Medical Q3 net loss widens to $3.6M; expenses up 25% on CEO separation costs","bullets":["Net loss of $3.6M for fiscal Q3 ended Dec 31, 2023, vs $2.8M a year ago.","Operating expenses $3.6M (+25% YoY), driven by $873K in former CEO separation costs.","Cash balance $8.0M as of Dec 31, 2023; company focusing on expense reduction.","Received DCGI clearance in India for phase 1 trial of Hemopurifier in solid tumors.","In vitro binding study results inconclusive; engaging third-party labs for independent assays."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-24-000985","json":"https://secwatch.observer/filing/0001683168-24-000985.json","markdown":"https://secwatch.observer/filing/0001683168-24-000985.md","text":"https://secwatch.observer/filing/0001683168-24-000985.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/882291/000168316824000985/0001683168-24-000985-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/882291/000168316824000985/aethlon_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T02:54:00.310146+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4e21d92a2751f9049f8515758356bddda1edca21","claim":"AETHLON MEDICAL INC reported fiscal third quarter ended December 31, 2023 results: net income $3.6 million.","evidence_excerpt":"On February 14, 2024, Aethlon Medical, Inc. issued a press release announcing its financial results for the quarter ended December 31, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/882291/000168316824000985/0001683168-24-000985-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal third quarter ended December 31, 2023"},{"label":"Net income","value":"$3.6 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}